Vincerx Pharma (VINC) Stock Chart & Stock Price History $0.04 0.00 (-1.28%) As of 08/15/2025 12:19 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vincerx Pharma Stock Price Performance The Vincerx Pharma (VINC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.68%, with a year-to-date return of -99.26%. In the past month, the stock has decreased 18.53%, reflecting recent market activity. As of the latest close, Vincerx Pharma traded at $0.04 with a market cap of $203 thousand and volume of 81,852 shares. Receive VINC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.76%1 Month Performance-18.53%3 Month Performance-29.64%Year-To-Date Performance-99.26%1 Year Performance-99.68% VINC Stock Chart for Saturday, August, 16, 2025 VINC Chart by TradingView Vincerx Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$0.04$0.04-1.28%$0.04$0.0481,852 shs$203,000.0008/14/2025$0.04$0.04+0.26%$0.05$0.0417,374 shs$205,000.0008/13/2025$0.04$0.04+10.45%$0.05$0.0420,548 shs$205,000.0008/12/2025$0.04$0.04-11.06%$0.04$0.0483,802 shs$185,000.0008/11/2025$0.04$0.04$0.04$0.0487,167 shs$208,000.0008/08/2025$0.05$0.04-18.78%$0.05$0.03183,586 shs$208,000.0008/07/2025$0.04$0.05+33.15%$0.05$0.04160,967 shs$256,000.0008/06/2025$0.03$0.04+8.55%$0.07$0.0332,638 shs$193,000.0008/05/2025$0.04$0.03-5.57%$0.04$0.0344,536 shs$177,000.0008/04/2025$0.04$0.04-0.55%$0.05$0.0372,848 shs$188,000.00 Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$0.04$0.04-9.07%$0.04$0.0422,584 shs$189,000.0007/31/2025$0.04$0.04+7.59%$0.04$0.0438,579 shs$208,000.0007/30/2025$0.04$0.04-7.75%$0.05$0.0424,524 shs$193,000.0007/29/2025$0.05$0.04-13.42%$0.06$0.04205,938 shs$209,000.0007/28/2025$0.05$0.05+0.43%$0.06$0.056,922 shs$242,000.0007/25/2025$0.06$0.05-21.77%$0.06$0.0571,085 shs$241,000.0007/24/2025$0.05$0.06+7.10%$0.06$0.0578,661 shs$308,000.0007/23/2025$0.06$0.05-3.68%$0.06$0.059,778 shs$287,000.0007/22/2025$0.05$0.06+15.15%$0.07$0.05107,813 shs$298,000.0007/21/2025$0.05$0.05+9.51%$0.05$0.05249,398 shs$259,000.0007/18/2025$0.05$0.05-0.88%$0.05$0.0465,748 shs$237,000.0007/17/2025$0.05$0.05-4.00%$0.05$0.0471,376 shs$239,000.0007/16/2025$0.04$0.05+10.47%$0.05$0.0474,595 shs$249,000.0007/15/2025$0.05$0.04-7.53%$0.05$0.0423,523 shs$225,000.00 Related Companies BPTSY Stock Chart ORGS Stock Chart HEPA Stock Chart VIRX Stock Chart NCNA Stock Chart TRVN Stock Chart MYMD Stock Chart CAPS Stock Chart BON Stock Chart UPC Stock Chart Receive VINC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VINC) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access